Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-15

Clinical Trial Update: TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy [Phase 3]

View source ↗

Summary

Phase 3 extension study for TH9507 in HIV-associated lipodystrophy has completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TH9507

Snippet

Sponsor: Theratechnologies | Conditions: Lipodystrophy, HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2014-01-15